Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Marginal Zone Lymphoma
Related studies linked through entity extraction aliases.
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine for Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2